Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol Echocardiography for Cardiovascular Disorders
NCT05769868Phase 3Recruiting
- Sponsor
- CiberMed
- Start
- Apr 2023
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esmolol in Cardiovascular Disease (CVD), sponsored by CiberMed. Started Apr 2023; status: recruiting.
02
Drugs
esmolol
03
Conditions
Cardiovascular Disease (CVD)
Beyond the preview
Go deeper on NCT05769868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05769868.